Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of parkinson’s disease

Author： Meissner Wassilios   Prunier Caroline   Guilloteau Denis   Chalon Sylvie   Gross Christian   Bezard Erwan  

Publisher： Humana Press, Inc

ISSN： 0893-7648

Source： Molecular Neurobiology, Vol.28, Iss.3, 2003-12, pp. : 209-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene therapy for Parkinson’s disease

By Le Hoang N   Frim David M  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 2, 2002-02 ,pp. : 151-161

Informa Healthcare

Access to resources Recommend Favorite

MPTP as a Mitochondrial Neurotoxic Model of Parkinson's Disease: Mitochondria and Neuroprotection—In Memory of Albert L. Lehninger

By Przedborski Serge   Tieu Kim   Perier Celine   Vila Miquel  

Journal of Bioenergetics and Biomembranes, Vol. 36, Iss. 4, 2004-08 ,pp. : 375-379

Springer Publishing Company

Access to resources Recommend Favorite

Proteomic approach to studying parkinson’s disease

By Zhang Jing   Goodlett David  

Molecular Neurobiology, Vol. 29, Iss. 3, 2004-06 ,pp. : 271-288

Humana Press, Inc

Access to resources Recommend Favorite

Environmental toxins and α-synuclein in Parkinson’s disease

By Liu Yanying   Yang Hui  

Molecular Neurobiology, Vol. 31, Iss. 1-3, 2005-02 ,pp. : 273-282

Humana Press, Inc

Access to resources Recommend Favorite

Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson’s disease

By Bonsi P.   Cuomo D.   Picconi B.   Sciamanna G.   Tscherter A.   Tolu M.   Bernardi G.   Calabresi P.   Pisani A.  

Amino Acids, Vol. 32, Iss. 2, 2007-02 ,pp. : 189-195

Springer Publishing Company

Access to resources Recommend Favorite